pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,867 catalysts · 5,627 phase readout · 2,292 8k filing · 240 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 49 catalysts2026-08-06: 13 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 3 catalysts2026-10-28: 2 catalysts2026-10-29: 8 catalysts2026-10-30: 3 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: earnings×type: filing×clear all
type
  • phase readout5,627
  • 8k filing2,292
  • earnings240
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT03025334: tDCS on Parkinson's Disease Cognition

Sponsor: University of Manitoba. Phase: NA. Conditions: Parkinson Disease, Mild Cognitive Impairment

full page →ctgov ↗
›COMPLETEDphase readoutNCT07581964: Effect of Sleep Apnea on Pain After Dental Treatment

Sponsor: Harran University. Phase: . Conditions: Obstructive Sleep Apnea, Postoperative Pain, Hypertension Complicated With Type 2 Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT05232032: Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation

Sponsor: Mclean Hospital. Phase: PHASE2. Conditions: Depressive Disorder, Major, Anxiety Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT02998398: Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Rheumatoid Arthritis, Spondyloarthritis, Crohn's Disease, Uveitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07329998: The Aim of the Study is to Check Whether Follicular Fluid Evaluation Using a Spectrophotometer Can Differentiate High Quality Oocytes From Low Quality Oocytes. Oocyte Quality Will be Defined Using GDF9, BMP15 and Oocyte Morphology.

Sponsor: Hillel Yaffe Medical Center. Phase: NA. Conditions: Oocyte Quality Assessment Using Spectrophotometer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02653287: Lupus Intervention for Fatigue Trial

Sponsor: Northwestern University. Phase: NA. Conditions: Fatigue, Physical Activity, Lupus Erythematosus, Systemic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07503821: Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Synovitis Villonodular

full page →ctgov ↗
›RECRUITINGphase readoutNCT05677321: Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA). Phase: . Conditions: Alcohol Use Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03012321: Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Sponsor: Northwestern University. Phase: PHASE2. Conditions: Prostate Cancer Metastatic Castration-Resistant, Abnormal DNA Repair, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427914: Effectiveness and Safety of Benemix® in Constipation

Sponsor: Universidad de Antioquia. Phase: NA. Conditions: Constipation - Functional

full page →ctgov ↗
›RECRUITINGphase readoutNCT06075914: Ketone Conferred Resiliency Against Sleep Restriction With Nutritional Intervention.

Sponsor: Ohio State University. Phase: NA. Conditions: Sleep Deprivation, Nutritional Intervention

full page →ctgov ↗
›COMPLETEDphase readoutNCT01843504: Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy

Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Chronic Patellar Tendinopathy, Chronic PT

full page →ctgov ↗
›COMPLETEDphase readoutNCT02158884: PRIORITI-MTF Study- Testing Patient Response to the IDEO

Sponsor: Major Extremity Trauma Research Consortium. Phase: NA. Conditions: Leg Injuries, Trauma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07399184: Effect of Perioperative IV Ibuprofen on Cerebral Oxygenation and Postoperative Cognition During One-Lung Ventilation

Sponsor: Ondokuz Mayıs University. Phase: NA. Conditions: Postoperative Delirium, Cerebral Oxygen Saturation, Postoperative Cognitive Dysfunction (POCD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06829784: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.. Phase: PHASE3. Conditions: Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07532733: Respiratory and Haemodynamic Effects of Conscious Sedation With Dexmedetomidine for a TAVI Procedure

Sponsor: Erasme University Hospital. Phase: NA. Conditions: TAVI(Transcatheter Aortic Valve Implantation)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07502352: Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)

Sponsor: University of Miami. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06947538: Stepped Care for Posttraumatic Stress Disorder Study

Sponsor: Boston Medical Center. Phase: NA. Conditions: Post Traumatic Stress Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07350252: Combination of Nerve Blocks and Local Infiltration Analgesia in Knee Arthroplasty

Sponsor: Region Skane. Phase: PHASE4. Conditions: Osteo Arthritis of the Knee

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03770338: Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Osteoporosis, Fusion of Spine, Lumbar Region

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06899958: Metabolism Enhancement by Laser Therapy

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Metabolism Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07664826: Acupuncture Mechanism in Relief of Gag Reflex

Sponsor: University Medicine Greifswald. Phase: NA. Conditions: Gag (Pharyngeal) Reflex

full page →ctgov ↗
›RECRUITINGphase readoutNCT05833555: Harlem Strong Mental Health Coalition

Sponsor: City University of New York, School of Public Health. Phase: NA. Conditions: Stress-related Problem, Depression, Anxiety, Mental Health Wellness

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05944926: Improving Outcomes in Depression in Primary Care in a Low Resource Setting

Sponsor: Harvard Medical School (HMS and HSDM). Phase: PHASE3. Conditions: Depression, Depressive Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06702878: Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Sponsor: Ondine Biomedical Inc.. Phase: PHASE3. Conditions: Surgical Site Infections, Surgical Wound Infection, Infections, Anti-Infective Agents

full page →ctgov ↗
›RECRUITINGphase readoutNCT06446765: Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder

Sponsor: Yale University. Phase: PHASE2. Conditions: Borderline Personality Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT04188067: TMS for the Treatment of Primary Progressive Aphasia

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Logopenic Variant Primary Progressive Aphasia, Non-fluent Variant Primary Progressive Aphasia, Semantic Variant Primary Progressive Aphasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07374367: Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings

Sponsor: Amera Imam Abdel - Ghany Ahmed. Phase: . Conditions: Disease Activity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07696000: The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy

Sponsor: DINA KEUMALA SARI. Phase: NA. Conditions: Schizophrenia / Schizoaffective Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07566208: Using Mirabegron to Control Arrhythmia-1

Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: Ventricular Arrhythmias and Cardiac Arrest

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07484035: Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA)

Sponsor: Heilongjiang Feihe Dairy Co. Ltd.. Phase: NA. Conditions: Cow's Milk Protein Allergy (CMPA)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04074135: Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07345117: Cost-effectiveness and Implementation of a Transdiagnostic Internet-based Intervention for Emotional Disorders in Community Care.

Sponsor: Universitat Jaume I. Phase: NA. Conditions: Emotional Disorders, Depression Anxiety Disorder, Depression Disorders, Anxiety Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT02603640: " Virtual Brain "-Based Interpretation of Electrophysiological Signals in Epilepsy

Sponsor: Assistance Publique Hopitaux De Marseille. Phase: NA. Conditions: Epilepsy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07087340: Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis

Sponsor: University of Bern. Phase: NA. Conditions: Type-1-Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT06507150: AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance

Sponsor: Ente Ospedaliero Cantonale, Bellinzona. Phase: NA. Conditions: Migraine

full page →ctgov ↗
›COMPLETEDphase readoutNCT05628350: Highly Processed Foods and Vascular Health

Sponsor: Virginia Polytechnic Institute and State University. Phase: NA. Conditions: Cardiovascular Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07185191: Evaluation of the Safety and Performance of the Medical Device RDM36 in the Treatment of Periodontal Gingival Contraction and in Black Triangles Syndrome (BTS)

Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Black Triangles Syndrome (BTS), Periodontal Gingival Contraction

full page →ctgov ↗
›COMPLETEDphase readoutNCT07052890: Curcumin, Vitamin D and Green Tea in IBS-D

Sponsor: Dr Anthony Hobson. Phase: NA. Conditions: Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome With Diarrhea (IBS-D)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05960890: Cohort Study of Chronic Heart Failure

Sponsor: Jiangsu Taizhou People's Hospital. Phase: NA. Conditions: Heart Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT04593810: Effect of Automated Closed-Loop Ventilation Versus Conventional Ventilation on Duration and Quality of Ventilation

Sponsor: Prof. Dr. Marcus J. Schultz. Phase: NA. Conditions: Ventilator-free Days, Quality of Breathing

full page →ctgov ↗
›COMPLETEDphase readoutNCT02213913: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Sponsor: University of Chicago. Phase: PHASE1. Conditions: Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Progressive Hairy Cell Leukemia, Initial Treatment, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage 0 Chronic Lymphocytic Leukemia, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Small Lymphocytic Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Testicular Lymphoma, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia

›COMPLETEDphase readoutNCT05911360: A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF

Sponsor: ViiV Healthcare. Phase: PHASE3. Conditions: HIV, HIV Infections

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07498660: PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial)

Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Osteoarthitis, Sacro Iliac Joint Pain, Hip Arthroplasty, Total, Sacro-Iliac Spondylosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07684820: To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Sponsor: Expedition Therapeutics, Inc. Phase: PHASE2. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02629120: High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Chronic Granulomatous Disease Transplant

full page →ctgov ↗
›RECRUITINGphase readoutNCT07310420: A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

Sponsor: TerSera Therapeutics LLC. Phase: PHASE1. Conditions: Advanced Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07617220: FIRST-Sask Study Protocol: A Remote Exercise Oncology Intervention

Sponsor: University of Saskatchewan. Phase: NA. Conditions: Exercise Oncology

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07399782: Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea

Sponsor: Hospital Felicio Rocho. Phase: PHASE2. Conditions: Sleep Apnea Syndrome, Obstructive, Sleep Apnea Syndrome (OSAS), Sleep Apnea/Hypopnea Syndrome, Sleep Apnea - Obstructive

full page →ctgov ↗
›COMPLETEDphase readoutNCT07202182: Creative Drama-Based Stress Management Program on Stress, Coping, and Emotional Intelligence

Sponsor: Gazi University. Phase: NA. Conditions: Emotional Intelligence, Creative Drama, Coping, Nursing, Undergraduate

full page →ctgov ↗
← prev
page 116 of 118
next →
full page →ctgov ↗